Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lessons from HIV and hepatitis viruses.

S L Sacks1, P D Griffiths, L Corey

  • 1Viridae, Vancouver, Canada.

Antiviral Research
|September 29, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementation of Positive Advanced Recovery Connections in Primary and Secondary Mental Health Care-A Registered Advanced Nurse Practitioner-Led Initiative.

Journal of advanced nursing·2024
Same author

Gut microbiota analysis and faecal transplantation to improve surgical outcomes.

The British journal of surgery·2023
Same author

Chemical characterisation of the vapour emitted by an e-cigarette using a ceramic wick-based technology.

Scientific reports·2022
Same author

Conservation in a Region of Political Instability: Bwindi Impenetrable Forest, Uganda.

Conservation biology : the journal of the Society for Conservation Biology·2022
Same author

Quality of internet information to aid patient decision making in locally advanced and recurrent rectal cancer.

The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·2022
Same author

The Chemical Complexity of e-Cigarette Aerosols Compared With the Smoke From a Tobacco Burning Cigarette.

Frontiers in chemistry·2021
Same journal

The anti-respiratory syncytial virus activity of biochemicals from Pyrola incarnata.

Antiviral research·2026
Same journal

Ginsenoside Rb2-based inactivation enables a Zika vaccine that maintains pregnancy and protects offspring against virus.

Antiviral research·2026
Same journal

ITGA4 drives pathogenesis of flavivirus and inhibition of it protects mice against Japanese encephalitis virus infection.

Antiviral research·2026
Same journal

Corrigendum to "A virus-like particle candidate vaccine based on CRISPR/Cas9 gene editing technology elicits broad-spectrum protection against SARS-CoV-2" [Antivir. Res. 225 (2024) 105854].

Antiviral research·2026
Same journal

Effects of RNA polymerase inhibitors on nucleotidylylation of human norovirus VPg.

Antiviral research·2026
Same journal

Human monoclonal antibodies from donors vaccinated with recombinant vaccinia vaccine targeting A35 and B6 effectively inhibit orthopoxvirus spread and infection.

Antiviral research·2026
See all related articles

Surrogate markers and statistical models are crucial for understanding viral diseases like HIV, aiding in therapy and vaccine evaluation. They also help study HIV transmission and pathogenesis, offering new research approaches.

Area of Science:

  • Virology
  • Infectious Diseases
  • Biostatistics

Background:

  • Surrogate markers are vital for studying viral disease management and prevention.
  • Statistical models enhance the understanding of viral pathogenesis and transmission.
  • Their application is particularly significant in the context of Human Immunodeficiency Virus (HIV).

Purpose of the Study:

  • To highlight the importance of surrogate markers and statistical models in virology.
  • To explore their application in evaluating therapies and vaccines for HIV.
  • To examine their role in understanding HIV transmission and pathogenesis.

Main Methods:

  • Review of existing literature on surrogate markers in viral diseases.
  • Analysis of statistical model applications in HIV research.

Related Experiment Videos

  • Comparative analysis of viral load as a predictor in Hepatitis B and C infections.

    • Main Results:

    • Surrogate markers and statistical models offer novel approaches for HIV therapy and vaccine evaluation.
    • Viral load is not the sole predictor of Hepatitis B transmission.
    • For Hepatitis C, cumulative viral load, not current viral load, influences outcomes, with therapy targeting replication.

    Conclusions:

    • Surrogate markers and statistical models are indispensable tools in advancing the study of viral diseases, especially HIV.
    • These methods facilitate a deeper understanding of disease progression, transmission, and treatment efficacy.
    • Further development and application of these tools will accelerate progress in combating viral infections.